Olgu Sunumu
BibTex RIS Kaynak Göster
Yıl 2022, Cilt: 5 Sayı: 1, 104 - 106, 01.01.2022
https://doi.org/10.19127/bshealthscience.930247

Öz

Kaynakça

  • Adelman M, Albelda SM, Gottlieb J, Haponik EF. 1984. Diagnostic utility of pleural fluid eosinophilia. The American J Med, 77(5): 915-920.
  • André S, Drowart A, De Bels D. 2005. Lymphocytic pleural effusion associated with valproic acid. European J Inter Med, 16(7): 535.
  • Antony VB. 1998. Drug-induced pleural disease. Clinics in chest Med, 19(2): 331-340.
  • Bally C, Martin C, Kraoua S, Kanaan R, Lacronique J, Dusser D, Burgel P. 2011. Eosinophilic pleural effusion related to taking valproic acid. Revue de Pneum Clin, 67(6): 363.
  • Heidecker J, Kaplan A, Sahn SA. 2006. Pleural fluid and peripheral eosinophilia from hemothorax: Hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. The American J Med Sci, 332(3): 148-152.
  • Huggins JT, Sahn SA. 2004. Drug-induced pleural disease. Clinics in Chest Med, 25(1): 141-153.
  • Kalomenidis I, Light RW. 2003. Eosinophilic pleural effusions. Current Opin Pulmon Med, 9(4): 254-260.
  • Kaufman J, O'Shaughnessy IM. 1995. Eosinophilic pleural effusion associated with valproic acid administration. Southern Med J, 88(8): 881-882.
  • Krenke R, Nasilowski J, Korczynski P, Gorska K, Przybylowski T, Chazan R, Light RW. 2009. Incidence and aetiology of eosinophilic pleural effusion. European Respir J, 34(5): 1111-1117.
  • Rubins JB, Rubins HB. 1996. Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study. Chest, 110(5): 1271-1274.

Eosinophilic Pleuropericardial Effusion due to Valproic Acid

Yıl 2022, Cilt: 5 Sayı: 1, 104 - 106, 01.01.2022
https://doi.org/10.19127/bshealthscience.930247

Öz

Valproic acid is widely used in the treatment of many diseases. It has common side effects such as nausea, vomiting, diarrhea, dizziness, tremor, hair loss, thrombocytopenia. Valproic acid can rarely cause eosinophilic pleuropericardial effusion. Case report; a 31-year-old male patient who had been using valproic acid since childhood due to epilepsy presented with respiratory distress. Eosinophilic pleuropericardial effusion was detected in the examinations performed in the patient with progressive respiratory distress. After excluding other etiological causes, this condition is assumed to be related to valproic acid. Drug changes were made. The end of six months, was observed to be completely cured. Conclusion: This adverse is generally thought to result from drug hypersensitivity reaction. But it is seen that it is an important factor in drug dosage.

Kaynakça

  • Adelman M, Albelda SM, Gottlieb J, Haponik EF. 1984. Diagnostic utility of pleural fluid eosinophilia. The American J Med, 77(5): 915-920.
  • André S, Drowart A, De Bels D. 2005. Lymphocytic pleural effusion associated with valproic acid. European J Inter Med, 16(7): 535.
  • Antony VB. 1998. Drug-induced pleural disease. Clinics in chest Med, 19(2): 331-340.
  • Bally C, Martin C, Kraoua S, Kanaan R, Lacronique J, Dusser D, Burgel P. 2011. Eosinophilic pleural effusion related to taking valproic acid. Revue de Pneum Clin, 67(6): 363.
  • Heidecker J, Kaplan A, Sahn SA. 2006. Pleural fluid and peripheral eosinophilia from hemothorax: Hypothesis of the pathogenesis of EPE in hemothorax and pneumothorax. The American J Med Sci, 332(3): 148-152.
  • Huggins JT, Sahn SA. 2004. Drug-induced pleural disease. Clinics in Chest Med, 25(1): 141-153.
  • Kalomenidis I, Light RW. 2003. Eosinophilic pleural effusions. Current Opin Pulmon Med, 9(4): 254-260.
  • Kaufman J, O'Shaughnessy IM. 1995. Eosinophilic pleural effusion associated with valproic acid administration. Southern Med J, 88(8): 881-882.
  • Krenke R, Nasilowski J, Korczynski P, Gorska K, Przybylowski T, Chazan R, Light RW. 2009. Incidence and aetiology of eosinophilic pleural effusion. European Respir J, 34(5): 1111-1117.
  • Rubins JB, Rubins HB. 1996. Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study. Chest, 110(5): 1271-1274.
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular İç Hastalıkları
Bölüm Olgu Sunumu
Yazarlar

Fatma Şimşek 0000-0003-1662-5534

Nazım Kızıldağ 0000-0003-1655-5695

Yayımlanma Tarihi 1 Ocak 2022
Gönderilme Tarihi 30 Nisan 2021
Kabul Tarihi 1 Aralık 2021
Yayımlandığı Sayı Yıl 2022 Cilt: 5 Sayı: 1

Kaynak Göster

APA Şimşek, F., & Kızıldağ, N. (2022). Eosinophilic Pleuropericardial Effusion due to Valproic Acid. Black Sea Journal of Health Science, 5(1), 104-106. https://doi.org/10.19127/bshealthscience.930247
AMA Şimşek F, Kızıldağ N. Eosinophilic Pleuropericardial Effusion due to Valproic Acid. BSJ Health Sci. Ocak 2022;5(1):104-106. doi:10.19127/bshealthscience.930247
Chicago Şimşek, Fatma, ve Nazım Kızıldağ. “Eosinophilic Pleuropericardial Effusion Due to Valproic Acid”. Black Sea Journal of Health Science 5, sy. 1 (Ocak 2022): 104-6. https://doi.org/10.19127/bshealthscience.930247.
EndNote Şimşek F, Kızıldağ N (01 Ocak 2022) Eosinophilic Pleuropericardial Effusion due to Valproic Acid. Black Sea Journal of Health Science 5 1 104–106.
IEEE F. Şimşek ve N. Kızıldağ, “Eosinophilic Pleuropericardial Effusion due to Valproic Acid”, BSJ Health Sci., c. 5, sy. 1, ss. 104–106, 2022, doi: 10.19127/bshealthscience.930247.
ISNAD Şimşek, Fatma - Kızıldağ, Nazım. “Eosinophilic Pleuropericardial Effusion Due to Valproic Acid”. Black Sea Journal of Health Science 5/1 (Ocak 2022), 104-106. https://doi.org/10.19127/bshealthscience.930247.
JAMA Şimşek F, Kızıldağ N. Eosinophilic Pleuropericardial Effusion due to Valproic Acid. BSJ Health Sci. 2022;5:104–106.
MLA Şimşek, Fatma ve Nazım Kızıldağ. “Eosinophilic Pleuropericardial Effusion Due to Valproic Acid”. Black Sea Journal of Health Science, c. 5, sy. 1, 2022, ss. 104-6, doi:10.19127/bshealthscience.930247.
Vancouver Şimşek F, Kızıldağ N. Eosinophilic Pleuropericardial Effusion due to Valproic Acid. BSJ Health Sci. 2022;5(1):104-6.